Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01856036 · ClinicalTrials.gov registry record · NA
Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers
A NA study, sponsored by Saint John's Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01856036 is a NA study that was terminated before completion, run by Saint John's Cancer Institute. The registered enrollment target is 2 participants.
The verdict
NCT01856036, a NA study, was terminated before completion, sponsored by Saint John's Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This protocol will study the impact of cryoablation on immune response in patients diagnosed with invasive breast cancers smaller than 1.5 cm. It will profile the immune response to cryoablation of invasive breast cancers. The intra-tumoral and systemic immune response to cryoablation will be determined and compared to pre-ablated breast cancer specimens and historical control specimens.
Interventions
- PROCEDURE Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01856036
The ClinicalTrials.gov registry entry for NCT01856036 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saint John's Cancer Institute, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cryoablation is the first listed.
NCT01856036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01856036 about?
NCT01856036 is a clinical study titled "Anti-Tumor Immunity Induced by Cryoablation of Invasive Breast Cancers". This protocol will study the impact of cryoablation on immune response in patients diagnosed with invasive breast cancers smaller than 1.5 cm. It will profile the immune response to cryoablation of invasive breast cancers. The intra-tumoral and systemic immune response to cryoablation will be determ...
What is the current status of trial NCT01856036?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2013-04. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01856036?
The interventions under investigation include: Cryoablation (PROCEDURE).
Who is sponsoring clinical trial NCT01856036?
This trial is sponsored by Saint John's Cancer Institute, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.